Lantheus Holdings Inc (LNTH)
78.18
+10.79
(+16.01%)
USD |
NASDAQ |
May 02, 16:00
78.21
+0.03
(+0.04%)
After-Hours: 07:45
Lantheus Holdings Enterprise Value: 5.206B for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 5.206B |
| May 01, 2024 | 4.467B |
| April 30, 2024 | 4.409B |
| April 29, 2024 | 4.458B |
| April 26, 2024 | 4.341B |
| April 25, 2024 | 4.317B |
| April 24, 2024 | 4.317B |
| April 23, 2024 | 4.263B |
| April 22, 2024 | 4.171B |
| April 19, 2024 | 4.221B |
| April 18, 2024 | 4.120B |
| April 17, 2024 | 4.062B |
| April 16, 2024 | 4.079B |
| April 15, 2024 | 3.978B |
| April 12, 2024 | 4.015B |
| April 11, 2024 | 4.063B |
| April 10, 2024 | 3.951B |
| April 09, 2024 | 3.989B |
| April 08, 2024 | 3.943B |
| April 05, 2024 | 4.017B |
| April 04, 2024 | 3.945B |
| April 03, 2024 | 3.905B |
| April 02, 2024 | 3.883B |
| April 01, 2024 | 3.968B |
| March 28, 2024 | 4.114B |
| Date | Value |
|---|---|
| March 27, 2024 | 3.992B |
| March 26, 2024 | 3.875B |
| March 25, 2024 | 3.894B |
| March 22, 2024 | 3.893B |
| March 21, 2024 | 3.873B |
| March 20, 2024 | 3.904B |
| March 19, 2024 | 3.853B |
| March 18, 2024 | 3.722B |
| March 15, 2024 | 3.835B |
| March 14, 2024 | 3.949B |
| March 13, 2024 | 3.938B |
| March 12, 2024 | 4.021B |
| March 11, 2024 | 4.147B |
| March 08, 2024 | 4.133B |
| March 07, 2024 | 4.138B |
| March 06, 2024 | 4.095B |
| March 05, 2024 | 4.265B |
| March 04, 2024 | 4.328B |
| March 01, 2024 | 4.278B |
| February 29, 2024 | 4.329B |
| February 28, 2024 | 4.328B |
| February 27, 2024 | 4.526B |
| February 26, 2024 | 4.518B |
| February 23, 2024 | 4.390B |
| February 22, 2024 | 4.306B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
462.97M
Minimum
Mar 18 2020
6.897B
Maximum
May 12 2023
2.756B
Average
1.885B
Median
Jul 13 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 1.008B |
| Boston Scientific Corp | 114.43B |
| Edwards Lifesciences Corp | 50.23B |
| NeuroMetrix Inc | -9.118M |
| Stryker Corp | 134.89B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 103.38M |
| Revenue (Quarterly) | 354.00M |
| Total Expenses (Quarterly) | 216.51M |
| EPS Diluted (Quarterly) | 1.47 |
| Gross Profit Margin (Quarterly) | 64.93% |
| Profit Margin (Quarterly) | 29.20% |
| Earnings Yield | 5.94% |
| Operating Earnings Yield | 6.69% |
| Normalized Earnings Yield | 5.228 |